Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Freeman

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of Cutaneous Pathology|August 1, 1996
Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five casesJ R De Vito, A J Merogi, T Vo, et al.
Frontiers in Pharmacology|April 27, 2026
Oral 18-methoxycoronaridine activity in simian and murine <i>Leishmania amazonensis</i> infectionJ C Delorenzi, T S Melo, F T Silveira, et al.
Human Gene Therapy|August 20, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 28, 1999
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 1, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|February 4, 1998
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|April 25, 2000
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Cutaneous Pathology|August 1, 1996
Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five casesJ R De Vito, A J Merogi, T Vo, et al.
Frontiers in Pharmacology|April 27, 2026
Oral 18-methoxycoronaridine activity in simian and murine <i>Leishmania amazonensis</i> infectionJ C Delorenzi, T S Melo, F T Silveira, et al.
Human Gene Therapy|August 20, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 28, 1999
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 1, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|February 4, 1998
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|April 25, 2000
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Pageof 6